Why the study?
Oxidative damage is implicated in AF but antioxidants are ineffective, leading the authors to test whether highly reactive isolevuglandins drive AF during hypertension.
Does 2-HOBA prevent atrial fibrillation susceptibility and IsoLG/PAO formation in a hypertensive murine model?
Does 2-HOBA prevent atrial fibrillation susceptibility and IsoLG/PAO formation in a hypertensive murine model?
Answers are grounded in this paper and cite their sources.
Pre-emptively scavenging reactive downstream oxidative stress mediators with 2-HOBA prevents atrial fibrillation susceptibility in a hypertensive murine model.
Oxidative damage is implicated in atrial fibrillation (AF), but antioxidants are ineffective therapeutically. The authors tested the hypothesis that highly reactive lipid dicarbonyl metabolites, or isolevuglandins (IsoLGs), are principal drivers of AF during hypertension. In a hypertensive murine model and stretched atriomyocytes, the dicarbonyl scavenger 2-hydroxybenzylamine (2-HOBA) prevented IsoLG adducts and preamyloid oligomers (PAOs), and AF susceptibility, whereas the ineffective analog 4-hydroxybenzylamine (4-HOBA) had minimal effect. Natriuretic peptides generated cytotoxic oligomers, a process accelerated by IsoLGs, contributing to atrial PAO formation. These findings support the concept of pre-emptively scavenging reactive downstream oxidative stress mediators as a potential therapeutic approach to prevent AF.
No takes yet. Share an insight, caveat, or question.
Prinsen et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: